07:00 , Apr 15, 2013 |  BC Week In Review  |  Clinical News

Zintevir integrase inhibitor data

At the Interscience Conference on Antimicrobial Agents and Chemotherapy in Toronto, ARNX reported the pharmacokinetics of Zintevir, tested at single doses of 0.75, 1.5, 3 or 6 mg/kg, or in multiple doses of 1.5 or...
08:00 , Feb 21, 2005 |  BioCentury  |  Product Development

New focus on HIV pipeline

The emergence of a case of AIDS in New York that is resistant to 17 of the 20 marketed drugs is a reminder that the four classes of existing drugs only address three targets on...
07:00 , Jul 19, 2004 |  BioCentury  |  Product Development

Cancer test bed

For patients with renal cell carcinoma, few treatment options exist beyond surgical removal of the kidney. The only approved drug for metastatic RCC is Proleukin aldesleukin, a recombinant version of interleukin-2 from Chiron Corp. (CHIR,...
07:00 , Jun 24, 2002 |  BC Week In Review  |  Company News

Aronex other research news

Researchers published in the Proceedings of the National Academy of Sciences evidence that adaptive immunity cooperates with pharmacologic therapy to induce or maintain remissions in APL. Lipo ATRA treatment of immune competent mice adoptively transferred...
08:00 , Dec 10, 2001 |  BC Week In Review  |  Company News

Dyax management update

Dyax Corp. (DYAX), Cambridge, Mass.   Business: Diagnostics/Imaging, Supply/Service   Hired: Anthony Williams as SVP of medical affairs and clinical operations, formerly CMO and VP for medical affairs at Aronex Pharmaceuticals Inc. ; and Lynn...
07:00 , Oct 22, 2001 |  BC Week In Review  |  Company News

NewBiotics management update

NewBiotics Inc., San Diego, Calif.   Business: Cancer, Infectious diseases   Hired: Paul Cossum as EVP of drug development, formerly VP of preclinical R&D and business development at Aronex Pharmaceuticals Inc.  ...
07:00 , Aug 13, 2001 |  BC Week In Review  |  Company News

Tanox Corp. management update

Tanox Corp. (TNOX), Houston, Texas   Business: Autoimmune/Inflammation, Antibodies   Hired: Seenu Srinivasan as VP of manufacturing operations, formerly VP of pharmaceutical development and operations at Aronex Pharmaceuticals Inc.  ...
07:00 , Jul 23, 2001 |  BC Week In Review  |  Company News

Genzyme Transgenics management update

Genzyme Transgenics Corp. (GZTC), Framingham, Mass.   Business: Biomanufacturing, Cardiovascular   Hired: Geoffrey Cox, a director, as chairman and CEO, formerly chairman and CEO of Aronex Pharmaceuticals Inc. ; former chairman James Geraghty will remain...
07:00 , Jul 19, 2001 |  BC Extra  |  Company News

Cox to head Genzyme Transgenics

GZTC, which is producing therapeutics in the milk of transgenic animals, named Geoffrey Cox, a company director, as chairman and CEO. Former chairman James Geraghty will remain a director. Most recently, Cox was chairman and...
07:00 , Jul 16, 2001 |  BC Week In Review  |  Company News

Antigenics, Aronex deal

AGEN completed its previously announced acquisition of ARNX (see BioCentury, April 30). ARNX shareholders will receive 0.0594 AGEN shares for each ARNX share held, and may receive up to an additional $0.15 per ARNX share...